Combined Effects of Benidipine and Diltiazem on Cardiohemodynamics in Anesthetized Dogs(Pharmacognosy)
スポンサーリンク
概要
- 論文の詳細を見る
We examined the combined effects of the calcium channel blockers 1, 4-dihydropyridine (benidipine) and benzothiazepine (diltiazem) on cardiohemodynamics in anesthetized dogs. Benidipine (3μg/kg) lowered blood pressure (BP) slightly and continuously increased coronary flow (CF). Diltiazem (300, 1000μg/kg) decreased BP, heart rate (HR), and the maximum rate of rise of left ventricular pressure (LV dP/dt max) with the increase of doses. Diltiazem increased CF, though it was transient when compared to benidipine. A combination of benidipine (3μg/kg) and diltiazem (300μg/kg) showed continuous decreases in BP, HR, and LV dP/dt max, and an increase in CF that was similar to that recorded for the benidipine group. The level of double product (DP: systolic BP×HR, an index of myocardium energy consumption) in the combination group was significantly lower than that of the benidipine group. The plasma concentrations of benidipine and diltiazem in the combination group were similar to those of the groups receiving either drug. These results demonstrate that the combination of benidipine and diltiazem increases CF more continuously than diltiazem alone, and decreases DP more potently than benidipine alone, indicating that the combination therapy possesses favorable properties as a treatment for angina pectoris. Therefore, the combination of benidipine and diltiazem is suggested as a useful treatment for improving the clinical benefits of monotherapy for angina, compared with the use of diltiazem alone at higher doses.
- 2006-04-01
著者
-
YAO Kozo
Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd.
-
MAEDA Hiroshi
Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd.
-
INA Yasuhiro
Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd.
-
SATO Miwa
Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd.
-
FUJITA Kazuhiro
Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd.
-
KUWABARA Takashi
Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd.
-
KOBAYASHI Hiroyuki
Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd.
-
SHIRAKURA Shiro
Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd.
-
Yao Kozo
Pharmaceutical Research Center Kyowa Hakko Kogyo Co Ltd
-
Ina Yasuhiro
Pharmaceutical Research Center Kyowa Hakko Kogyo Co. Ltd.
-
Sato Miwa
Pharmaceutical Research Center Kyowa Hakko Kogyo Co. Ltd.
-
Shirakura Shiro
Pharmaceutical Research Center Kyowa Hakko Kogyo Co. Ltd.
-
Kuwabara Takashi
Pharmaceutical Research Center Kyowa Hakko Kogyo Co. Ltd.
-
Fujita Kazuhiro
Pharmaceutical Research Center Kyowa Hakko Kogyo Co. Ltd.
-
Kobayashi Hiroyuki
Pharmaceutical Research Center Kyowa Hakko Kogyo Co. Ltd.
-
Maeda Hiroshi
Pharmaceutical Research Center Kyowa Hakko Kogyo Co. Ltd.
関連論文
- Combined Effects of Benidipine and Diltiazem on Cardiohemodynamics in Anesthetized Dogs(Pharmacognosy)
- Renoprotective Effects of Benidipine in Combination with Angiotensin II Type 1 Receptor Blocker in Hypertensive Dahl Rats
- Effects of Benidipine and Candesartan on Kidney and Vascular Function in Hypertensive Dahl Rats
- Effect of the Selective Adenosine A_1-Receptor Antagonist KW-3902 on Lipopolysaccharide-Induced Reductions in Urine Volume and Renal Blood Flow in Anesthetized Dogs
- Foam cells generated by a combination of hyperglycemia and hyperlipemia in rats
- Highly Sensitive Enzyme-Linked Immunosorbent Assay for Marograstim (KW-2228), a Mutant of Human Granulocyte Colony-Stimulating Factor
- Antioxidant Effects of Calcium Antagonists in Rat Brain Homogenates
- A POSSIBLE RELATIONSHIP BETWEEN ABORTIONS AND PLACENTAL EMBOLISM IN PREGNANT RABBITS GIVEN HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR
- Benidipine, a Dihydropyridine-Ca^ Channel Blocker, Increases the Endothelial Differentiation of Endothelial Progenitor Cells In Vitro
- LC-MS/MS coupled with immunoaffinity extraction for determination of estrone, 17β-estradiol and estrone 3-sulfate in human plasma
- The Contribution of Cytochrome P450 to the Metabolism of Tegafur in Human Liver
- Inhibitors of Acyl-CoA : Cholesterol Acyltransferase. II. Preparation and Hypocholesterolemic Activity of Optically Active Dibenz[b, e]oxepin-11-carboxanilides
- PJ-470 Benidipine, a Long-acting Calcium Channel Blocker, Improves Insulin Resistance beyond Antihypertensive Effects in Metabolic Syndrome Rats(Diabetes/Obesity/Metabolic syndrome(11)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the
- PJ-347 Acute Effects of Benidipine on Renal Hemodynamics and Tubular Reabsorption in Anesthetized Spontaneously Hypertensive Rats(Kidney/Renal circulation(06)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Socie
- P-glycoprotein Limits the Brain Penetration of Olopatadine Hydrochloride, H1-Receptor Antagonist
- Identification of Human P450 Isoforms Involved in the Metabolism of the Antiallergic Drug, Oxatomide, and Its Inhibitory Effect on Enzyme Activity (Miscellaneous)
- Identification of Human P450 Isoforms Involved in the Metabolism of the Antiallergic Drug, Oxatomide, and Its Kinetic Parameters and Inhibition Constants(Miscellaneous)
- Determination of olopatadine, a new antiallergic agent, and its metabolites in human plasma by high-performance liquid chromatography with electrospray ionization tandem mass spectrometry